{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:11:02Z","timestamp":1760037062133,"version":"build-2065373602"},"reference-count":24,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["2022.03263.PTDC","COMPETE2030-FEDER-00661600","UID\/04539\/2025","UID\/PRR\/04539\/2025","LA\/P\/0058\/2020"],"award-info":[{"award-number":["2022.03263.PTDC","COMPETE2030-FEDER-00661600","UID\/04539\/2025","UID\/PRR\/04539\/2025","LA\/P\/0058\/2020"]}]},{"name":"FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["2022.03263.PTDC","COMPETE2030-FEDER-00661600","UID\/04539\/2025","UID\/PRR\/04539\/2025","LA\/P\/0058\/2020"],"award-info":[{"award-number":["2022.03263.PTDC","COMPETE2030-FEDER-00661600","UID\/04539\/2025","UID\/PRR\/04539\/2025","LA\/P\/0058\/2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroSci"],"abstract":"<jats:p>Different neurodegenerative diseases display varying etiologies and phenotypes, reflecting region-specific neurodegeneration [...]<\/jats:p>","DOI":"10.3390\/neurosci6040102","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T12:04:52Z","timestamp":1759925092000},"page":"102","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NMDA Receptor: An Old but Refreshed Target for Neurodegeneration"],"prefix":"10.3390","volume":"6","author":[{"given":"Joana M.","family":"Marques","sequence":"first","affiliation":[{"name":"CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"CiBB-Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7631-743X","authenticated-orcid":false,"given":"Ricardo J.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"CiBB-Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.164.3880.719","article-title":"Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate","volume":"164","author":"Olney","year":"1969","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.1994.tb44407.x","article-title":"Calcium and excitotoxic neuronal injury","volume":"747","author":"Choi","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_3","first-page":"57","article-title":"Excitotoxicity and the NMDA receptor\u2013still lethal after eight years","volume":"18","author":"Rothman","year":"1995","journal-title":"Trends Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2613.2000.00169.x","article-title":"The pathogenic activation of calpain: A marker and mediator of cellular toxicity and disease states","volume":"81","author":"Vanderklish","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/B:JOBB.0000041755.22613.8d","article-title":"Deadly conversations: Nuclear-mitochondrial cross-talk","volume":"36","author":"Dawson","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Beaurain, M., Salabert, A.S., Payoux, P., Gras, E., and Talmont, F. (2024). NMDA receptors: Distribution, role, and insights into neuropsychiatric disorders. Pharmaceuticals, 17.","DOI":"10.3390\/ph17101265"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/neurosci3010009","article-title":"Effectiveness of double-hit model (post-weaning social isolation and NMDA receptor antagonist) in the development of schizophrenic like symptoms on rodents: A protocol for a systematic review","volume":"3","author":"Shangase","year":"2022","journal-title":"NeuroSci"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Thomas, A., and Chambers, R.A. (2025). Ketamine\u2019s therapeutic role in substance use disorders: A narrative review. NeuroSci, 6.","DOI":"10.3390\/neurosci6030083"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: Impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1523\/JNEUROSCI.20-01-00022.2000","article-title":"Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity","volume":"20","author":"Sattler","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neuron.2004.08.011","article-title":"2004 Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors","volume":"43","author":"Fellin","year":"2004","journal-title":"Neuron"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Papouin, T., and Oliet, S.H. (2014). Organization, control and function of extrasynaptic NMDA receptors. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 369.","DOI":"10.1098\/rstb.2013.0601"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhang, K., Wen, M., Nan, X., Zhao, S., Li, H., Ai, Y., and Zhu, H. (2025). NMDA receptors in neurodegenerative diseases: Mechanisms and emerging therapeutic strategies. Front. Aging Neurosci., 17.","DOI":"10.3389\/fnagi.2025.1604378"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/neurosci3040043","article-title":"P2Y1 receptor as a catalyst of brain neurodegeneration","volume":"3","author":"Rodrigues","year":"2022","journal-title":"NeuroSci"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41419-018-0351-1","article-title":"Glutamate-induced and NMDA receptor-mediated neurodegeneration entails P2Y1 receptor activation","volume":"9","author":"Silva","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yan, J., Bengtson, C.P., Buchthal, B., Hagenston, A.M., and Bading, H. (2020). Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants. Science, 370.","DOI":"10.1126\/science.aay3302"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Yan, J., and Bading, H. (2023). The disruption of NMDAR\/TRPM4 death signaling with TwinF interface inhibitors: A new pharmacological principle for neuroprotection. Pharmaceuticals, 16.","DOI":"10.3390\/ph16081085"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wang, Y.M., Yan, J., Williams, S.K., Fairless, R., and Bading, H. (2024). TwinF interface inhibitor FP802 prevents retinal ganglion cell loss in a mouse model of amyotrophic lateral sclerosis. Acta Neuropathol Commun., 12.","DOI":"10.1186\/s40478-024-01858-0"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yan, J., Wang, Y.M., Hellwig, A., and Bading, H. (2024). TwinF interface inhibitor FP802 stops loss of motor neurons and mitigates disease progression in a mouse model of ALS. Cell Rep. Med., 5.","DOI":"10.1016\/j.xcrm.2024.101413"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yan, J., Yang, X., Li, G., Ramirez, O.A., Hagenston, A.M., Chen, Z.Y., and Bading, H. (2025). The NMDAR\/TRPM4 death complex is a major promoter of disease progression in the 5xFAD mouse model of Alzheimer\u2019s disease. Mol. Psychiatry.","DOI":"10.1038\/s41380-025-03143-5"}],"container-title":["NeuroSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2673-4087\/6\/4\/102\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:50:24Z","timestamp":1760035824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2673-4087\/6\/4\/102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["neurosci6040102"],"URL":"https:\/\/doi.org\/10.3390\/neurosci6040102","relation":{},"ISSN":["2673-4087"],"issn-type":[{"type":"electronic","value":"2673-4087"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}